2025-05-09 08:35
Correction: Interim Report for Ortivus AB (publ) for the period January - March 2025
“Our ambition is not only to deliver technology, but to be a strategic partner in the transformation of healthcare.”
“Our ambition is not only to deliver technology, but to be a strategic partner in the transformation of healthcare.”
The Board of Directors of Ortivus AB has resolved to withdraw its proposal that the Board be granted authorisation by the Annual General Meeting to issue class B shares, etc. The proposal is withdrawn in its entirety.
The Board of Directors of Ortivus AB has resolved to withdraw its proposal that the Board be granted authorisation by the Annual General Meeting to issue class B shares, etc. The proposal is withdrawn in its entirety.
2025-03-11 16:00
We are pleased to welcome two new colleagues to Ortivus!
During February, we have strengthened our leadership team with Gabriel Åhbeck as Chief Technology Officer (CTO) and Emma Mattsson as Chief Marketing Officer (CMO). With Emma and Gabriel on board, we gain a powerful boost in our efforts towards innovation...
2025-02-14 08:30
Ortivus: Year-end report January-December 2024
During the year, we have carried out extensive organisational changes and strengthened our team to support our growth journey. Additionally, we have implemented a new business system to improve financial control and the monitoring of our key metrics...
2024-12-17 14:40
The Implementation of MobiMed 5 and Integration with Cambio Cosmic in Region Norrbotten
Region Norrbotten has successfully trained all staff and launched the next-generation medical record system, MobiMed 5, replacing the previous system, Aweria.
2024-12-16 18:00
Ortivus will change its listing to Nasdaq First North Growth Market on December 19, 2024
Ortivus AB (publ) ("Ortivus" or the "Company") has applied for and today received approval for admission to trading on the Nasdaq First North Growth Market. The first day of trading on the Nasdaq First North Growth Market will be December 19, 2024.
2024-11-08 08:30
Change process continues during third quarter
"During the year, we have made significant progress, which those of you who have followed our reports have surely seen. While we have streamlined our cost structure, we have placed great focus on completing new products that we see as having great potential...
The largest owners in Ortivus AB (publ) have appointed their representatives in the nomination committee ahead of the 2025 annual general meeting, which will be held on May 8, 2025.